Model N Announces Fall Life Science and High Tech Customer Advisory Board Meetings

Share Article

Semi-annual meetings provide opportunity for customers, partners, and model n management to discuss emerging industry trends, plan a common revenue management vision, and collaborate on product direction.

The Customer Advisory Board is a critical component in creating a dialog around Revenue Management among our Life Science and High Tech customers, partners, government agencies, and Model N

Model N, Inc., the leader in Revenue Management solutions, today announced its semi-annual Life Science and High Tech Customer Advisory Board (CAB) meetings.

This September, Model N executives will gather with customers and partners from both the life science and high tech industries to help develop and nurture an ongoing strategic partnership. As part of Model N's industry-focused strategy, the CAB meetings create a discourse with customers and partners on their requirements, successes, and best practices using Revenue Management solutions, the product roadmap, and go-to-market strategies for new initiatives.

As a major component of Model N's customer engagement plan, which includes Lighthouse programs for early adopters and Preferred Design Partner programs, the CAB meetings provide Model N with important direction on product development and enhancements by facilitating a collaborative forum with customers and partners. They also help develop a sense of community by enabling discussions on best practices for eliminating revenue leakage and avoiding regulatory exposure with Model N solutions, as well as exploring new opportunities for Revenue Management innovation. Both meeting agendas will include a progress review from the most recent CAB events in March of 2007, which were attended by High Tech customers Cypress Semiconductor Corp. (NASDAQ: CY); Intersil Corp. (NASDAQ: ISIL); ON Semiconductor, Inc. (NASDAQ: ONNN); and Microchip Technology, Inc. (NASDAQ: MCHP) and Life Science customers Bristol-Myers Squibb Co. (NYSE: BMY); Boston Scientific Corp. (NYSE: BSX); C.R. Bard, Inc. (NYSE: BCR); King Pharmaceuticals, Inc. (NYSE: KG); and Ortho-Clinical Diagnostics, a Johnson & Johnson Company (NYSE: JNJ).

"The Model N Customer Advisory Board has proven to be a productive vehicle for getting important questions answered and delivering feedback on Model N solutions," stated Colum O'Neill, Director of Sales Processes and Toolsets at ON Semiconductor. "The effort Model N puts into preparing for CAB meetings and the opportunity given to customers to meaningfully contribute to product strategy discussions make participating in the Model N CAB program a very worthwhile endeavor."

"By uniting strategic thinkers and operational experts from Model N's customer base in an active community, the Customer Advisory Board enables our organization to consult with other early adopters of revenue management on best practices and project approaches, as well as take part in an ongoing discussion around continuing product excellence," said Ray Almeida, Director, Business Analytics at Boston Scientific Corp. "In turn, the Board affords Model N the opportunity to directly interact with customers and garner feedback that helps set the direction for future product development."

In addition to discussing product direction and best practices, the CAB meetings allow Model N management to examine important industry trends with customers. As life science and high tech organizations continue to face growing regulatory and competitive pressures, the meetings create a productive environment for exploring how Model N and customers can work together to address these challenges.

"The Customer Advisory Board is a critical component in creating a dialog around Revenue Management among our Life Science and High Tech customers, partners, government agencies, and Model N," said Zack Rinat, Model N Founder and CEO. "We will take this opportunity to work together in setting a bold common vision for Revenue Management, agreeing on multi-year strategy to achieve this vision, and prioritizing the product roadmap accordingly."

About Model N
Model N is the leader in Revenue Management solutions, offering an integrated suite of applications for analytics, pricing strategy and execution, contracts, compliance, rebates, fees, and chargebacks optimized for the industry practices of Life Science and High Tech companies. Enabling the creation of a seamless, end-to-end process from price setting through settlements payment, Model N's uniquely integrated approach eliminates revenue leakage and delivers the visibility and controls needed to avoid the risks of non-compliance to government reporting regulations such as Sarbanes-Oxley and government pricing requirements. Customers include: Boston Scientific Corporation; Bristol-Myers Squibb Company; Cypress Semiconductor Corporation; Intersil Corporation; Linear Technology Corporation; Medtronic, Inc.; Microchip Technology, Inc.; Micron Technology Inc.; Ortho-Clinical Diagnostics, a Johnson & Johnson company; ON Semiconductor, Inc.; and Pfizer, Inc. Model N is located in Redwood Shores, California. For additional information, visit http://www.modeln.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Megan Reilly